Trial · NCT03759340
Adverse events23
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 23
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Ear pain | Ear and labyrinth disorders | ATI 502 0.46% Topical Solution | 1 | 56 | 1 |
| other | Application site dryness | General disorders | ATI 502 0.46% Topical Solution | 2 | 56 | 2 |
| other | Application site pruritus | General disorders | ATI 502 0.46% Topical Solution | 2 | 56 | 2 |
| other | Application site rash | General disorders | ATI 502 0.46% Topical Solution | 1 | 56 | 1 |
| other | Folliculitis | Infections and infestations | ATI 502 0.46% Topical Solution | 1 | 56 | 1 |
| other | Nasopharyngitis | Infections and infestations | ATI 502 0.46% Topical Solution | 1 | 56 | 1 |
| other | Pyuria | Infections and infestations | ATI 502 0.46% Topical Solution | 1 | 56 | 1 |
| other | Upper respiratory tract infection | Infections and infestations | ATI 502 0.46% Topical Solution | 3 | 56 | 3 |
| other | Ankle fracture | Injury, poisoning and procedural complications | ATI 502 0.46% Topical Solution | 1 | 56 | 1 |
| other | Foot fracture | Injury, poisoning and procedural complications | ATI 502 0.46% Topical Solution | 1 | 56 | 1 |
| other | Muscle strain | Injury, poisoning and procedural complications | ATI 502 0.46% Topical Solution | 2 | 56 | 2 |
| other | White blood cell count increased | Investigations | ATI 502 0.46% Topical Solution | 1 | 56 | 1 |
| other | Arthritis | Musculoskeletal and connective tissue disorders | ATI 502 0.46% Topical Solution | 1 | 56 | 1 |
| other | Osteoarthritis | Musculoskeletal and connective tissue disorders | ATI 502 0.46% Topical Solution | 1 | 56 | 1 |
| other | Skin papilloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | ATI 502 0.46% Topical Solution | 1 | 56 | 1 |
| other | Carpal tunnel syndrome | Nervous system disorders | ATI 502 0.46% Topical Solution | 1 | 56 | 1 |
| other | Insomnia | Psychiatric disorders | ATI 502 0.46% Topical Solution | 1 | 56 | 1 |
| other | Dermal cyst | Skin and subcutaneous tissue disorders | ATI 502 0.46% Topical Solution | 1 | 56 | 1 |
| other | Dermatitis | Skin and subcutaneous tissue disorders | ATI 502 0.46% Topical Solution | 2 | 56 | 2 |
| other | Dyshidrotic eczema | Skin and subcutaneous tissue disorders | ATI 502 0.46% Topical Solution | 1 | 56 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03759340/events